Mycronic AB (publ) (LON:0MQG)

London flag London · Delayed Price · Currency is GBP · Price in SEK
290.20
-9.20 (-3.07%)
At close: May 12, 2026
Market Cap4.67B +60.0%
Revenue (ttm)660.40M +10.6%
Net Income131.70M -8.8%
EPS0.67 -8.9%
Shares Outn/a
PE Ratio35.46
Forward PE37.89
Dividend0.26 (0.09%)
Ex-Dividend DateMay 7, 2026
Volume14,506
Average Volume39,289
Open295.40
Previous Close299.40
Day's Range290.20 - 297.60
52-Week Range174.60 - 385.00
Beta0.72
RSI71.65
Earnings DateJul 14, 2026

About Mycronic AB

Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors. The PCB Assembly segment develops, manufactures, and markets flex... [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1989
Employees 2,673
Stock Exchange London Stock Exchange
Ticker Symbol 0MQG

Financial Performance

In 2025, Mycronic AB's revenue was 7.94 billion, an increase of 12.48% compared to the previous year's 7.06 billion. Earnings were 1.56 billion, a decrease of -7.31%.

Financial numbers in SEK Financial Statements

News

Mycronic AB Earnings Call Transcript: Q1 2026

Q1 delivered record sales and EBIT, driven by strong demand in High Volume and Global Technologies, leading to an upgraded 2026 sales outlook. Pattern Generators saw robust sales but lower order intake, while PCB Assembly Solutions remained weak. AI and OLED trends continue to support growth.

19 days ago - Transcripts

Mycronic AB Earnings Call Transcript: Q4 2025

Order intake declined 19% year-over-year, but sales remained flat as strong growth in Global Technologies offset declines elsewhere. EBIT margin was 17% for the quarter, with continued R&D investment and a positive outlook for Global Technologies and High Volume divisions.

3 months ago - Transcripts

Mycronic AB Earnings Call Transcript: Q3 2025

Order intake surged 67% year-over-year, led by Pattern Generators and Global Technologies, while sales dipped 4% and EBIT margin fell to 15% due to product mix. Backlog and cash remain strong, with continued M&A activity and a positive full-year outlook.

7 months ago - Transcripts

Mycronic AB Earnings Call Transcript: Q2 2025

Q2 saw 35% sales growth and a 27% EBIT margin, with strong performance in Pattern Generators and High Volume, but order intake declined due to no new system orders. Three acquisitions and a share split were completed, and full-year sales guidance was reaffirmed at SEK 7.5 billion.

10 months ago - Transcripts